MRI features for predicting the pathological grade of HCC in patients undergoing liver transplantation
Tóm tắt
Contrast-enhanced magnetic resonance imaging (MRI) plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC). This study aims to assess the performance of MRI features for evaluating hepatocellular carcinoma (HCC) aggressiveness in living liver transplantation in patients. This retrospective study included patients who underwent liver transplantation in our hospital between 2015 and 2020. Abdominal contrast-enhanced MRIs of these patients were reviewed, and clinical, radiological, and histopathological findings of HCCs were recorded. The prognostic features of HCCs as determined by MRI were compared with Edmondson-Steiner (E-S) grades. Liver parenchyma fibrosis based on an apparent diffusion coefficient (ADC) map was correlated with histological subclassification of cirrhosis using the Laennec staging system. The study subjects included 37 men and 8 women with a mean age of 59.56 ± 7.81 (range: 25–72). The mean tumour size was 37.33 ± 22.27 mm (range: 10–118 mm), and nine tumours (23.1%) involved portal vein tumour thrombosis. There was a significant correlation between tumour grade and size (p = 0.007) and intratumoral fat (p = 0.014) even though no significant correlations between grade and mean ADC value, capsule appearance, presence of satellite lesions, smooth margin, imaging of the tumour feeding artery, and corona enhancement of HCC (p > 0.05) were found. There was a statistically significant correlation between mild (stage 4A) and moderate (stage 4B) fibrosis of non-tumorous liver parenchyma and ADC value (p < 0.001). Our study found that ADC values can be used to distinguish mild cirrhotic livers from moderate cirrhotic livers. Diffusion MRI might be used to diagnose the degree of liver fibrosis without histopathological analysis. According to our results, only intralesional fat and tumour size correlated with tumour grade, and as such, these parameters could be used as prognostic MRI biomarkers for HCC.
Tài liệu tham khảo
Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156(2):477–491. https://doi.org/10.1053/j.gastro.2018.08.065
Hartke J, Johnson M, Ghabril M (2017) The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol 34(2):153–159. https://doi.org/10.1053/j.semdp.2016.12.011
Yang JD, Heimbach JK (2020) New advances in the diagnosis and management of hepatocellular carcinoma. BMJ 371:m3544. https://doi.org/10.1136/bmj.m3544
Ronot M, Purcell Y, Vilgrain V (2019) Hepatocellular carcinoma: current ımaging modalities for diagnosis and prognosis. Dig Dis Sci 64(4):934–950. https://doi.org/10.1007/s10620-019-05547-0
Jiang HY, Chen J, Xia CC, Cao LK, Duan T, Song B (2018) Noninvasive imaging of hepatocellular carcinoma: from diagnosis to prognosis. World J Gastroenterol 24(22):2348–2362. https://doi.org/10.3748/wjg.v24.i22.2348
Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–54. https://doi.org/10.1148/radiol.14132361
Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273(1):30–50. https://doi.org/10.1148/radiol.14132362
Kim SU, Oh HJ, Wanless IR, Lee S, Han KH, Park YN (2012) The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 57:556–563. https://doi.org/10.1016/j.jhep.2012.04.029
Levi Sandri GB, Lai Q, Bosco S, Berloco PB (2014) Liver splenosis mimicking hepatocellular carcinoma in cirrhotic liver. Liver Int 34(1):162. https://doi.org/10.1111/liv.12250
Morii K, Nakamura S, Yamamoto T, Okushin H (2014) Steatotic regenerative nodules mimicking hepatocellular carcinoma. Liver Int 34(3):477. https://doi.org/10.1111/liv.12256
Cho ES, Choi JY (2015) MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol 16(3):449–64. https://doi.org/10.3348/kjr.2015.16.3.449
Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP et al (2019) Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 25(21):2636–2649. https://doi.org/10.3748/wjg.v25.i21.2636
Cuccurullo V, Di Stasio GD, Mazzarella G, Cascini GL (2018) Microvascular ınvasion in HCC: the molecular ımaging perspective. Contrast Media Mol Imaging 2018:9487938. https://doi.org/10.1155/2018/9487938
Kim KA, Kim MJ, Jeon HM, Kim KS, Choi JS, Ahn SH et al (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634. https://doi.org/10.1002/jmri.22876
Gouw AS, Balabaud C, Kusano H, Todo S, Ichida T, Kojiro M (2011) Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17(Suppl 2):72–80. https://doi.org/10.1002/lt.22368
Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T et al (2009) Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 250(2):435–443. https://doi.org/10.1148/radiol.2501071702
Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M (2009) Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 193(2):438–444. https://doi.org/10.2214/AJR.08.1424
Kim MY, Cho MY, Baik SK, Park HJ, Jeon HK, Im CK et al (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55:1004–1009. https://doi.org/10.1016/j.jhep.2011.02.012.54
Sandrasegaran K, Akisik FM, Lin C et al (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. Am J Roentgenol 193:1556–1560. https://doi.org/10.2214/AJR.09.2436
Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ (2015) Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol 21(41):11567–11583. https://doi.org/10.3748/wjg.v21.i41.11567
Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S et al (2015) Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: a histopathologic correlation. Sci Rep 5:15408. https://doi.org/10.1038/srep15408